Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with (177)Lu-DOTATATE

BACKGROUND: Monitoring of pancreatic neuroendocrine tumors (PanNET) undergoing peptide receptor radionuclide therapy (PRRT) with (177)Lu-DOTATATE depends on changes in tumor size, which often occur late. Tumor growth rate (TGR) allows for quantitative assessment of the tumor kinetics expressed as %/...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Endocr Connect
Huvudupphovsmän: Pettersson, Olof Joakim, Fröss-Baron, Katarzyna, Crona, Joakim, Sundin, Anders
Materialtyp: Artigo
Språk:Inglês
Publicerad: Bioscientifica Ltd 2021
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111309/
https://ncbi.nlm.nih.gov/pubmed/33875614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-21-0027
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk